Fig 1.
Flow diagram depicting the design of the cross-sectional study conducted among MSM in China.
A 39.8% lifetime synthetic drug use prevalence was observed. Overall HIV prevalence was 7.8%, with a higher prevalence among those who had used synthetic drugs in their lifetimes (10.6%) compared to those who had never used these drugs (6.0%).
Table 1.
Characteristics of all participants, and participants grouped by lifetime synthetic drug use.
Table 2.
Results of univariate and multivariate regression models predicting factors associated with HIV-positive serostatus.